Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
meglumine (1 trial)
nitric oxide (inomax) (1 trial)
Leishmaniasis (Phase 3)
Leishmaniasis, Cutaneous (Phase 3)
Trials (1 total)
Trial APIs (2 total)